Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03498612
Title Pembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative Diseases
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington
Indications

follicular lymphoma

lymphoplasmacytic lymphoma

marginal zone B-cell lymphoma

CLL/SLL

Waldenstroem's macroglobulinemia

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.